Results 21 to 30 of about 9,172,807 (336)

Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England

Clinical Infectious Diseases, 2020
Background Streptococcus pneumoniae coinfection with influenza results in synergistic lethality, but there are limited data on pneumococcal coinfection with SARS-CoV-2.
Z. Amin-Chowdhury, F. Aiano, A. Mensah, C. Sheppard, D. Litt, N. Fry, N. Andrews, M. Ramsay, S. Ladhani   +8 more
semanticscholar   +1 more source

Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine [PDF]

Infectious Disease Clinics of North America, 2015
Universal immunization of infants and toddlers with pneumococcal conjugate vaccines over the last 15 years has dramatically altered the landscape of pneumococcal disease. Decreases in invasive pneumococcal disease, all-cause pneumonia, empyema, mastoiditis, acute otitis media, and complicated otitis media have been reported from multiple countries in ...
Inci Yildirim, Kimberly M. Shea, Stephen I. Pelton, Stephen I. Pelton   +3 more
openaire   +3 more sources

Standardizing Surveillance of Pneumococcal Disease [PDF]

Clinical Infectious Diseases, 2009
Surveillance for invasive pneumococcal disease has been conducted using a variety of case ascertainment methods and diagnostic tools. Interstudy differences in observed rates of invasive pneumococcal disease could reflect variations in surveillance methods or true epidemiological differences in disease incidence.
Knoll, MD, Moïsi, J, Muhib, F, Wonodi, C, Lee, E, Grant, L, Gilani, Z, Anude, C, O'Brien, K, Cherian, T, Levine, O, Adhikari, N, Anh, D, Baggett, H, Batu, R, Brooks, A, Dowell, S, El Arifeen, S, English, M, Fisher, J, Gessner, B, Kelly, D, Kilgore, P, Lafourcade, B, Lalitha, M   +24 more
openaire   +4 more sources

Sugar-Coated Killer: Serotype 3 Pneumococcal Disease

Frontiers in Cellular and Infection Microbiology, 2020
Capsular polysaccharide (CPS), which surrounds the bacteria, is one of the most significant and multifaceted contributors to Streptococcus pneumoniae virulence.
J. Luck, H. Tettelin, C. Orihuela
semanticscholar   +1 more source

A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy

Children, 2022
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause significant morbidity and mortality in children. We studied the annual incidence of pneumococcal-specific and syndromic invasive disease and non-invasive ...
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti, Carlo Giaquinto   +9 more
doaj   +1 more source

Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease

Pediatrics, 2020
Two PCVs are licensed for prevention of pneumococcal disease. Uncertainty about the effectiveness against AOM and serotype 19A invasive disease in children ≤5 years remains.
Melissa Berman-Rosa, Shauna O’Donnell, Mackenzie Barker, C. Quach   +3 more
semanticscholar   +1 more source

Pneumococcal vaccination in celiac disease [PDF]

Expert Review of Gastroenterology & Hepatology, 2019
Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure in genetically predisposed subjects. Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients. Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition in both the general population and celiac ...
Casella G, Ingravalle F, Abbate G, Monti C, Bonetti F, Bassotti G, Mansueto P, Villanacci V, Carroccio A.   +8 more
openaire   +5 more sources

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Lancet Global Health, 2020
Summary Background The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype
N. Bar-Zeev, T. Swarthout, D. Everett, M. Alaerts, J. Msefula, C. Brown, Sithembile Bilima, J. Mallewa, Carina King, A. von Gottberg, J. Verani, C. Whitney, C. Mwansambo, S. Gordon, N. Cunliffe, N. French, R. Heyderman   +16 more
semanticscholar   +1 more source

Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study

BMC Infectious Diseases, 2020
Background Streptococcus pneumoniae infections can lead to severe morbidity and mortality, especially in patients with invasive pneumococcal disease (IPD).
Tyson Chan, Min Zhi Tay, Win Mar Kyaw, Angela Chow, Hanley J. Ho   +4 more
doaj   +1 more source

IL-17 can be protective or deleterious in murine pneumococcal pneumonia [PDF]

, 2018
Streptococcus pneumoniae is the major bacterial cause of community-acquired pneumonia, and the leading agent of childhood pneumonia deaths worldwide. Nasal colonization is an essential step prior to infection.
Bayes, Hannah K., Evans, Tom J., Mitchell, Tim J., Ritchie, Neil D., Ritchie, Ryan   +4 more
core   +3 more sources